Guadecitabine sodium is under clinical development by Astex Pharmaceuticals and currently in Phase II for T-Cell Lymphomas.

Patritumab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). According to ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

BECAUSE of the frequency of lung and liver metastasis in the spread of certain malignant tumors it has long been accepted that malignant tumors may invade blood vessels, particularly veins, and ...